Emerging evidence demonstrates that GACAT3 is remarkably upregulated in CRC, HCC, breast cancer, NSCLC, bladder cancer, and glioma but shows diverse expression in GC cell lines. Here, GACAT3 is linked to hepatocellular carcinoma.